Bremer Trust National Association’s iShares Biotechnology ETF IBB Stock Holding History

Bremer Trust National Association’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	$60K	Buy	+627	New	+$66.5K	0.01%	417

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Natixis Paris, France $28B AUM 26.79% 1-Year Est. Return

Bremer Trust National Association's IBB Position: Q4 2018 in Review

Bremer Trust National Association opened a new position in iShares Biotechnology ETF (IBB) in Q4 2018: 627 shares worth $60K. The stake represents 0.01% of the portfolio and ranks #417 among its holdings.

649 funds tracked by Wall St. Rank hold IBB as of Q4 2018.

Bremer Trust National Association held 627 shares of iShares Biotechnology ETF worth $60K as of Q4 2018.
iShares Biotechnology ETF was a new Bremer Trust National Association position in Q4 2018.
iShares Biotechnology ETF made up 0.01% of Bremer Trust National Association's portfolio in Q4 2018, its #417 holding.
649 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q4 2018.

Based on Bremer Trust National Association's 13F filing for Q4 2018, filed 11 Feb 2019.